Migraine trials in Romania
2 trials · From ClinicalTrials.gov, checked 10 Nov 2026. Ask the study team whether a trial fits you.
Phase 3RecruitingTrial-stage medicine
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
- Where
- Bucharest, Bucuresti, Cluj-Napoca, Sibiu
- Age
- 6 years to 17 years
- People
- 450 worldwide
- Run by
- AbbVie
See details and how to joinNCT05711394EU 2022-501100-94-00Registry updated 2026-10-06
Phase 3Enrolling by invitationTrial-stage medicine
Long-term Extension Study to Assess Adverse Events of Oral Atogepant Tablets in Pediatric Participants (6 to 17 Years of Age) With Migraine
- Where
- Bucharest, Bucuresti, Cluj-Napoca
- Age
- 6 years to 17 years
- People
- 650 worldwide
- Run by
- AbbVie
See details and how to joinNCT05707949EU 2022-501099-24-00Registry updated 2025-08-11
All Migraine trials and the map
This page is not medical advice. Talk to your doctor before contacting a trial.